A detailed history of Narwhal Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Narwhal Capital Management holds 20,545 shares of PFE stock, worth $564,165. This represents 0.05% of its overall portfolio holdings.

Number of Shares
20,545
Previous 49,428 58.43%
Holding current value
$564,165
Previous $1.38 Million 57.02%
% of portfolio
0.05%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $800,059 - $906,637
-28,883 Reduced 58.43%
20,545 $594,000
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $785,055 - $919,938
-31,079 Reduced 38.6%
49,428 $1.38 Million
Q1 2024

Apr 26, 2024

SELL
$25.89 - $29.73 $1.46 Million - $1.67 Million
-56,252 Reduced 41.13%
80,507 $2.23 Million
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $689,649 - $895,778
-26,393 Reduced 16.18%
136,759 $3.94 Million
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $517,547 - $604,961
-16,128 Reduced 9.0%
163,152 $5.41 Million
Q2 2023

Aug 02, 2023

SELL
$36.12 - $41.79 $432,320 - $500,184
-11,969 Reduced 6.26%
179,280 $6.58 Million
Q1 2023

May 01, 2023

SELL
$39.39 - $51.28 $1.12 Million - $1.45 Million
-28,367 Reduced 12.92%
191,249 $7.8 Million
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $2.36 Million - $3.09 Million
-56,636 Reduced 20.5%
219,616 $11.3 Million
Q3 2022

Oct 31, 2022

SELL
$43.76 - $53.42 $416,507 - $508,451
-9,518 Reduced 3.33%
276,252 $12.1 Million
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $4.21 Million - $4.99 Million
90,419 Added 46.29%
285,770 $15 Million
Q1 2022

Apr 26, 2022

BUY
$45.75 - $56.69 $226,188 - $280,275
4,944 Added 2.6%
195,351 $10.1 Million
Q4 2021

Jan 26, 2022

BUY
$41.32 - $61.25 $713,555 - $1.06 Million
17,269 Added 9.97%
190,407 $11.2 Million
Q3 2021

Oct 22, 2021

BUY
$39.25 - $50.42 $1.04 Million - $1.34 Million
26,510 Added 18.08%
173,138 $7.45 Million
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $30,343 - $34,374
845 Added 0.58%
146,628 $5.74 Million
Q1 2021

Apr 23, 2021

SELL
$33.49 - $37.77 $203,418 - $229,414
-6,074 Reduced 4.0%
145,783 $5.28 Million
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $247,878 - $315,199
-7,406 Reduced 4.65%
151,857 $5.59 Million
Q3 2020

Oct 26, 2020

SELL
$31.75 - $37.25 $587,343 - $689,087
-18,499 Reduced 10.41%
159,263 $5.85 Million
Q2 2020

Jul 22, 2020

SELL
$30.12 - $36.54 $556,979 - $675,697
-18,492 Reduced 9.42%
177,762 $5.81 Million
Q1 2020

Apr 30, 2020

BUY
$27.03 - $38.62 $122,526 - $175,064
4,533 Added 2.36%
196,254 $6.41 Million
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $276,132 - $313,375
8,388 Added 4.58%
191,721 $7.51 Million
Q3 2019

Oct 31, 2019

SELL
$32.49 - $42.13 $58,806 - $76,255
-1,810 Reduced 0.98%
183,333 $6.59 Million
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $109,571 - $123,023
2,963 Added 1.63%
185,143 $8.02 Million
Q1 2019

Apr 12, 2019

SELL
$37.5 - $41.2 $53,137 - $58,380
-1,417 Reduced 0.77%
182,180 $7.74 Million
Q4 2018

Jan 15, 2019

SELL
$38.47 - $43.86 $98,098 - $111,843
-2,550 Reduced 1.37%
183,597 $8.01 Million
Q3 2018

Oct 23, 2018

SELL
$34.47 - $41.81 $8,962 - $10,870
-260 Reduced 0.14%
186,147 $8.2 Million
Q2 2018

Jul 19, 2018

SELL
$32.98 - $35.16 $37,300 - $39,765
-1,131 Reduced 0.6%
186,407 $6.76 Million
Q1 2018

Apr 17, 2018

BUY
$31.91 - $37.02 $526,770 - $611,126
16,508 Added 9.65%
187,538 $6.66 Million
Q4 2017

Jan 23, 2018

BUY
$33.26 - $35.29 $241,135 - $255,852
7,250 Added 4.43%
171,030 $6.2 Million
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $5.08 Million - $5.59 Million
163,780
163,780 $5.85 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Narwhal Capital Management Portfolio

Follow Narwhal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.